Our Approach to Treating Hodgkin and Non-Hodgkin Lymphomas
Lymphoma is a cancer that grows in cells that are part of the body’s immune system. There are two primary categories of lymphoma, and each type has its own unique characteristics. Both Hodgkin lymphoma (HL; also called Hodgkin disease) and non-Hodgkin lymphoma (NHL) originate in white blood cells called lymphocytes. The two types differ in how they behave, spread and respond to treatment. To diagnose the specific type of lymphoma, a physician needs to examine a sample of the affected tissue under a microscope.
Relatively rare, Hodgkin disease is one of the most curable forms of cancer. Non-Hodgkin lymphoma, by contrast, is one of the most common forms of cancer in the United States. NHL involves both aggressive and slow-growing types of tumors, and originates from immune B cells (B-cell lymphomas) or T cells (T-cell lymphomas).
Moffitt Cancer Center’s Malignant Hematology Program has a multispecialty team of experts who represent an array of disciplines that focus on lymphoma treatment and patient care. Our team is comprised of:
- Board-certified physicians
- Medical oncologists
- Radiation oncologists
- Other medical professionals
Our state-of-the-art laboratories and diagnostic imaging services help our team determine a patient’s specific type and stage of lymphoma. From there, these specialists all work together to design a comprehensive, individualized treatment plan for each patient and meet weekly to monitor his or her progress. In one convenient location, our patients have full access to all aspects of the most advanced lymphoma treatments available, including innovative therapies that are offered through our robust clinical trials program.
If you or someone you love is concerned about lymphoma or is interested in getting a second opinion on an existing cancer diagnosis, contact Moffitt Cancer Center by calling 1-888-MOFFITT or by filling out our online form. No referral is required.